Table 2.
3D iPSC-based Models of AD.
3D iPSC-based Models | Mutation/Genomic alteration | AD hallmarks | Reference (s) |
---|---|---|---|
fAD brain organoids/3D matrix | PSEN2 (N141I) | higher Aβ42/Aβ40 ratio, asynchronous calcium transients, enhanced neuronal hyperactivity | [82] |
fAD brain organoids | APOE4 | Aβ plaques and hyperphosphorylated Tau | [130] |
fAD organoids | APP duplication line/ PSEN1 (PSEN1M146I, PSEN1A264E) | higher amyloid aggregation and hyperphosphorylated Tau and endosomal abnormalities | [178] |
fAD and Down syndrome-organoids | PSEN1 (PSEN1A264E) | accumulation of structures reminiscent to and trisomy of ch21 (Ts21) amyloid plaques and neurofibrillary tangles | [179] |
fAD organoids | APOE4 | Aβ deposits, hyperphosphorylated Tau and decreased synaptic integrity | [180] |
3D human tri-culture in a | APP | Aβ aggregation, NFT formation, increased pro-inflammatory cytokines microfluidic platform microglial recruitment and neuron/astrocyte loss | [182] |
fAD-hippocampal spheroids | APP/PSEN1 | increased Ab42/Ab40 peptide ratios and decreased synaptic protein levels | [185] |